Epilepsy in CHAD: Realities, constraints, and prospects

Area of Science:

• Neurology
• Public Health
• Global Health

Background:

• Epilepsy affects over 50 million people globally, disproportionately impacting low- and middle-income countries.
• Chad faces substantial challenges in assessing and managing epilepsy due to data scarcity, inadequate facilities, and limited human resources.

Purpose of the Study:

• To describe the current situation of epilepsy treatment in Chad.
• To highlight the need for prioritizing epilepsy care and improving living conditions for individuals with epilepsy.

Main Methods:

• This study is a descriptive analysis of the current state of epilepsy care in Chad.
• Information was gathered on available resources, treatment accessibility, and socio-cultural factors impacting epilepsy management.

Main Results:

• Most epilepsy patients in Chad are undertreated or untreated, with limited access to antiseizure medications (ASMs).
• Significant barriers include inadequate healthcare infrastructure, a shortage of neurologists, cultural stigma (e.g., "devil's disease"), and insufficient social support, particularly in rural areas.
• Epilepsy is not a priority for decision-makers, leading to insufficient government action and social coverage.

Conclusions:

• Urgent government action is needed to prioritize epilepsy in national health plans.
• Improving diagnostic capabilities, increasing the availability of ASMs, and raising public awareness are crucial to overcome challenges and enhance care for people with epilepsy in Chad.